CHPA: CHPA pushes back on FDA proposal to reverse oral phenylephrine's OTC status

WASHINGTON -The Consumer Healthcare Products Association expressed strong disappointment in response to the U.S. Food and Drug Administration's recent proposal to reevaluate the status of over-the-counter (OTC) oral phenylephrine (PE), a widely used decongestant. The proposed order challenges FDA's longstanding recognition of PE as